Is the CSL (ASX:CSL) share price in the buy zone after its update?

The CSL Limited (ASX:CSL) share price is on the move on Wednesday following the release of a presentation. Is it time to buy shares?

| More on:
A doctor looks unsure, indicating share price uncertainty for ASX medical companies

Image source: Getty images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Limited (ASX: CSL) share price is on the move on Wednesday morning.

At the time of writing, the biotherapeutics giant's shares are up 1.5% to $275.25.

Why is the CSL share price on the move today?

This morning the biotherapeutics company released a presentation ahead of its appearance at the Macquarie Group Ltd (ASX: MQG) conference.

While the presentation didn't include a trading update for the third quarter of FY 2021, it did provide more colour on its plasma collections.

Plasma is a vital part of the process in the manufacturing of many of its therapies.

Over the last 12 months plasma collections have been under pressure due to COVID-19 related headwinds such as social distancing, lower mobility, and stimulus payments. The latter has reduced the need for some donors to make donations for an extra source of income.

What is the latest?

Management acknowledged that plasma collections have been adversely impact and additional collection costs have been incurred.

However, it has been mitigating this with a comprehensive campaign to raise awareness of the opportunity and need for plasma donation. Importantly, all its centres have remained open during the pandemic after being designated as essential critical infrastructure.

CSL has also continued to expand its footprint, with 25 new centres opening in the United States in the current financial year. This brings its network to over 300 cents, with the vast majority (284) in the United States market.

Pleasingly, management isn't resting on its laurels and intends to open a further 40 new centres in FY 2022.

Incidentally, a recent note out of Citi reveals that its analysts believe plasma collections will return to 2019 levels in the second half of 2021. If this proves accurate, CSL will be well-positioned to benefit thanks to its expanding network.

Is the CSL share price in the buy zone?

According to the aforementioned note out of Citi from late last month, the CSL share price is good value at present.

Citi currently has a buy rating and $310.00 price target on the company's shares.

Based on the current CSL share price, this price target implies potential upside of 12.5% over the next 12 months.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

A young smiling couple out hiking enjoy a view from the top of the mountains.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors enjoyed a rosy end to the trading week this Friday.

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Share Gainers

How these 3 ASX 200 stocks led the charge higher this week

The three top ASX 200 stocks are up 14% to 34% this week.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Imugene, Neuren, Sigma, and Smartgroup shares are charging higher

These shares are ending the week on a high. But why? Let's find out.

Read more »

A happy girl in a yellow playsuit with a zip gives the thumbs up
BNPL shares

Is this why the Zip share price keeps breaking records?

Zip shareholders have been enjoying a record breaking year. Is this why?

Read more »

A man and a woman sit in front of a laptop looking fascinated and captivated.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a volatile, but positive, day for ASX shares this Thursday.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Share Gainers

Why Block, GQG, Neuren, and Sigma shares are racing higher today

These shares are rising on Thursday. But why?

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Brainchip, Cooper Energy, Core Lithium, and Neuren shares are roaring higher today

These shares are having a good time on hump day. But why?

Read more »

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors endured a rough day of trading this Tuesday.

Read more »